The clinical role of liquid biopsy in oncology is growing significantly. In gliomas and other
brain tumours, targeted sequencing of cell-free DNA (cfDNA) from CSF may help differential …

Colorectal cancer (CRC) remains a leading cause of cancer-related deaths worldwide. In
recent years, liquid biopsy has emerged as one of the most interesting areas of research in …

Background Increasingly, circulating tumor DNA (ctDNA) is proposed as a tool for minimal
residual disease (MRD) assessment. Digital PCR (dPCR) offers low analysis costs and …

Recent breakthroughs in circulating tumor DNA (ctDNA) technologies present a compelling
opportunity to combine this emerging liquid biopsy approach with the field of radiogenomics …

Liquid biopsy, the detection of tumor-related DNA in the peripheral blood, is currently the
best available technological tool to improve clinical decision making in precision oncology. 1 …

Background No reliable marker has been identified to predict postoperative recurrence of
gastric cancer. We designed a clinical trial to investigate the utility of serum NY-ESO-1 …

Importance Chimeric antigen receptor (CAR) T-cell therapy has redefined the therapeutic
landscape of several hematologic malignant tumors. Despite its clinical efficacy, many …

Liquid biopsies enable early detection and monitoring of diseases such as cancer, but their
sensitivity remains limited by the scarcity of analytes such as cell-free DNA (cfDNA) in blood …

Simple Summary Colorectal cancer is a leading cause of cancer mortality, and its incidence
is rapidly increasing worldwide. Colorectal cancer is considered a single entity based on …

Simple Summary Registry data has the potential to support a broad range of research, audit
and education initiatives. Here, we describe the experience and learnings of a series of …